Obsidian Therapeutics, Inc. (OBX)
OBXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for OBX. That does not mean none is planned.
Get an email about OBX's next catalysts
Track Obsidian Therapeutics, Inc. (OBX) (OBX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
OBX-115 | Phase 2 | Tumor Skin | - | - |
Frequently asked questions
What is in Obsidian Therapeutics, Inc. (OBX)'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Obsidian Therapeutics, Inc. (OBX)'s (OBX) pipeline across Phase 2. Its lead program is OBX-115 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Obsidian Therapeutics, Inc. (OBX)'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Obsidian Therapeutics, Inc. (OBX) (OBX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track OBX biotech catalysts?→
Add OBX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Obsidian Therapeutics, Inc. (OBX)'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.